SHOUHUI GROUP, the parent company of the well-known insurance platform Xiaoyusan, recently released its first full-year financial report since going public. The report revealed that total premiums exceeded 11.2 billion yuan, a significant increase of 37% year-over-year, with first-year premium growth nearing 50%, indicating strong momentum for scale expansion.
However, behind these seemingly impressive figures lie multiple concerns, including a "shrinkage" in net profit, a decline in gross profit margin, and an over-reliance on a single business structure. These issues reflect the collective challenges faced by the insurance intermediary industry amid tightening regulations and a trend towards disintermediation.
The financial report shows that SHOUHUI GROUP's net profit for 2025 reached 794 million yuan, a dramatic surge of 685.2% year-over-year, successfully reversing the 136 million yuan loss recorded in 2024. However, a deeper analysis reveals questionable substance behind this figure: 619 million yuan of the profit originated from changes in the fair value of financial instruments. This essentially represents a paper gain from the conversion of pre-IPO preferred shares to ordinary shares and is unrelated to the company's core operations. After excluding this one-time accounting gain, the adjusted net profit was only 200 million yuan, a decrease of 17.1% compared to the previous year, indicating sustained pressure on true profitability.
The decline in gross profit margin further confirms the deterioration in profit quality. In 2025, SHOUHUI GROUP's overall gross profit margin plummeted from 38.1% to 32.9%. The gross profit margin for its core business, insurance transaction services, also dropped from 38.0% to 32.5%. The company attributed this primarily to the impact of the "unified reporting and execution" policy, which has put pressure on industry commission rates. Additionally, to capture market share in the long-term critical illness insurance segment, the company proactively increased commissions and promotional investments towards licensed brokerage partners and self-media traffic channels.
SHOUHUI GROUP's business is highly dependent on B2B partners for distribution and customer acquisition. The financial report indicates that revenue from its enterprise channel platform, "Niu Bao 100," accounts for over 60% of the total, highlighting significant channel concentration risk. Any loss of third-party partners or an increase in traffic acquisition costs could directly impact the company's performance.
Facing profitability pressures and stricter regulations, SHOUHUI GROUP is attempting to seek breakthroughs by adjusting its business structure and enhancing its technological capabilities. The report shows the company's intention to focus on high-stickiness products like health insurance and participating (dividend) insurance, with first-year premiums for participating products surging by 341.5% year-over-year. Simultaneously, the company continues to increase the application of AI technologies. While initiatives like intelligent underwriting and policy custody have contributed to lower operational costs, research and development expenses decreased by 5% in 2025, raising questions about the sustainability of its R&D investment.
Regarding its performance in the capital markets, SHOUHUI GROUP's IPO price was HKD 8.08. Within ten months, its share price was halved to HKD 3.12 (as of the market close on April 14), representing a decline of over 60%.
SHOUHUI GROUP's 2025 financial report marks a milestone in its pursuit of a 10-billion-yuan premium scale, but it also serves as a microcosm of the insurance intermediary industry's transition from extensive expansion to refined operations. In the context of the normalization of "unified reporting and execution," the sunset of the commission-driven era, and accelerated industry consolidation, the ultimate challenge for SHOUHUI GROUP and all insurance intermediaries will be how to reduce reliance on commissions and build differentiated competitive advantages.